Cost Effectiveness of Itraconazole in the Prophylaxis of Invasive Fungal Infections

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.1, 2008-01, pp. : 75-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Itraconazole prophylaxis of value for invasive fungal infections

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 544, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections

By Lestner Jodi

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 911-926

Informa Healthcare

Access to resources Recommend Favorite

Posaconazole: A Review of its Use in the Prophylaxis of Invasive Fungal Infections

By Frampton James E. Scott Lesley J.

Drugs, Vol. 68, Iss. 7, 2008-01 ,pp. : 993-1016

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS: An Overview and Methodological Discussion

By Freedberg K.A.

PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

Fungal Infections in Patients With Neutropenia: Challenges in Prophylaxis and Treatment

By Herbrecht R.

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 339-351

Adis International

Access to resources Recommend Favorite